Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Bicycle Therapeutics PLC changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 82 | 79 | −3 |
| Shares | 22.7M | 23.1M | +433.4K (+1.9%) |
| Value | $381.1M | $538.0M | +$156.9M (+41.2%) |
New holders (8)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 843,814 | $19.6M | 0.13% |
| Voya Investment Management LLC | 67,747 | $1.58M | 0.00% |
| L & S Advisors Inc | 42,765 | $995.0K | 0.18% |
| Octagon Capital Advisors LP | 20,000 | $465.0K | 0.08% |
| Deutsche Bank AG | 14,850 | $345.0K | 0.00% |
| Almanack Investment Partners, LLC. | 524 | $12.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 239 | $6.00K | 0.00% |
| Simplex Trading, LLC | 242 | $5.00K | 0.00% |
Sold out (11)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 153,200 | $2.57M |
| Qube Research & Technologies Ltd | 124,696 | $2.09M |
| Acadian Asset Management LLC | 56,909 | $954.0K |
| SG Americas Securities, LLC | 30,328 | $509.0K |
| Man Group plc | – | $233.0K |
| Trexquant Investment LP | 10,899 | $183.0K |
| Quantbot Technologies LP | 3,612 | $60.0K |
| High Net Worth Advisory Group LLC | 500 | $8.00K |
| Captrust Financial Advisors | 354 | $6.00K |
| BNP Paribas Arbitrage, SA | 333 | $5.59K |
| Wells Fargo & Company | 1 | $0 |